Legal Representation
Attorney
Justin L. Sage
USPTO Deadlines
Application History
49 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 18, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 18, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 9, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| May 3, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| May 8, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 3, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 9, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 7, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Nov 7, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Nov 7, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 20, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 18, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 18, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 18, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 4, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 2, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 2, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 2, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 24, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 22, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 22, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 22, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 10, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 6, 2020 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Nov 5, 2020 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Oct 19, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 19, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 19, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 19, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 19, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 29, 2020 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Sep 15, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 15, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 26, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 11, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 10, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 10, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 6, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 22, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 18, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 18, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 18, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 18, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 18, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 18, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 16, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 7, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 13, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes, all of the foregoing excluding reagents used in connection with demineralized bone for purposes other than diagnostic applications; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing dna, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with dna sequencing and genetic analysis
Class 005
In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis
Class 009
Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes; scientific instruments for use in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for dna sequencing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; downloadable software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable software used in analyzing, managing and visualizing dna sequencing data; downloadable software used for preparation of nucleic acids libraries; computer hardware and downloadble software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes
Classification
International Classes
001
005
009